BioSpace News Archive

Astellas and Universal Cells Ink $124M R&D Pact fo

Business

Cambridge’s Surface Oncology Promotes CBO to Top Job

Mr. Goater succeeds interim chief executive officer Dan Lynch, who will remain executive chairman of Surface’s board of directors.

February 12, 2018

·

3 min read

Drug Development

MabVax Therapeutics Announces Positive Interim Data From Expanded Cohort in Phase 1 Trial Evaluating MVT-5873 in Combination with First-Line Chemotherapy in Pancreatic Cancer

At the dose tested, all six patients in the cohort had meaningful reductions in tumor volume by RECIST.

February 12, 2018

·

5 min read

Business

Covalon Announces Strong First Quarter Financial Results

Total revenue for the three months ended December 31, 2017, was $6,404,705 compared to $5,608,994 for the same period of the prior year.

February 12, 2018

·

6 min read

Drug Development

Ra Pharmaceuticals Announces Completion of Dosing in Phase II Program of RA101495 SC in Paroxysmal Nocturnal Hemoglobinuria

Ra Pharmaceuticals announced today the completion of dosing and topline data for the Company’s global Phase 2 clinical program evaluating RA101495 SC for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).

February 12, 2018

·

8 min read

Business

Bonti Appoints Dr. Jacob Chacko to Board of Directors

Bonti today announced the appointment of Dr. Jacob Chacko to its Board of Directors, effective immediately.

February 12, 2018

·

2 min read

Business

ImmunoMet Appoints Vincent J. O’Neill, M.D., B.Sc., M.R.C.P, as CMO, and Allan L. Shaw as CFO

Dr. O’Neill, a medical oncologist, joins ImmunoMet with 16 years of oncology therapeutic and diagnostic product development experience at both large pharma and biotech companies.

February 12, 2018

·

3 min read

Biotech Bay

Pomona Valley Hospital Medical Center Adopting In-House IV Compounding with Omnicell’s IV Robotics

PVHMC joins many leading health systems who are adopting recommendations by The ISMP for the implementation of automation and technology in sterile compounding.

February 12, 2018

·

4 min read

Drug Development

CBSET: Preclinical Safety Studies Must Include Equally Balanced Male/Female Animal Models to Shed Light on Sex-Dependent Vascular Responses in Humans

CBSET announced today that its scientists have published data and analyses (“Sex differences in the outcomes of stent implantation in mini-swine model”) that “illustrate differences in the dynamic healing responses of male and female pigs to stent implantation in single and overlapped configurations.”

February 12, 2018

·

4 min read

Business

Horizon Discovery Enters into License Agreement With US Immuno-Oncology Company

Under the terms of the agreement, Horizon has licensed to the Partner a novel cell line engineering technology as well as non-exclusive rights to Horizon’s proprietary Helitron transposon gene editing technology for an undisclosed financial consideration.

February 12, 2018

·

2 min read

Pharm Country

Ferring’s CLENPIQ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep Now Available

Colorectal cancer is the third most common cancer and second leading cause of cancer death in the United States.

February 12, 2018

·

6 min read